%0 Journal Article
%T Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan.
%A Bajaj HS
%A Abouhassan T
%A Ahsan MR
%A Arnaout A
%A Hassanein M
%A Houlden RL
%A Khan T
%A Khandwala H
%A Verma S
%J Can J Diabetes
%V 43
%N 1
%D Feb 2019
%M 29804943
%F 2.774
%R 10.1016/j.jcjd.2018.04.007
%X <B>OBJECTIVE: </B>Fasting from dawn to dusk during Ramadan, including abstaining from water and food, is 1 of the pillars of Islam and is observed by the majority of Muslims. Most research concerning diabetes and fasting during Ramadan originates from Middle Eastern or South Asian countries; however, differences exist in hours of work and fasting, pharmacotherapy and blood glucose monitoring between these countries and Canada.<BR><B>METHODS: </B>An expert forum of 7 Canadian experts and 1 international expert collaborated to develop Canadian guidelines using the same evidence-based principles, with the exception of an independent methods review used for the Diabetes Canada clinical practice guidelines. Diabetes Canada scientific leadership and Canadian health-care providers performed independent external reviews. Religious leaders endorsed the position statement and provided letters of support. An informed patient participated in the position-statement development. Each recommendation was approved with 100% consensus of the expert forum.<BR><B>RESULTS: </B>Recommendations for risk stratification, education, pharmacotherapy and blood glucose monitoring for adults with type 1 and type 2 diabetes who intend to fast during Ramadan have been developed.<BR><B>CONCLUSIONS: </B>This is the first Canadian position statement on the topic of Ramadan fasting and diabetes. It was developed by an expert faculty and endorsed by Diabetes Canada, and provides guidance about pharmacotherapy and glucose monitoring for health-care providers so that they can assist Canadian Muslims living with diabetes to observe fasting during Ramadan safely.